Systemic approaches to improve cardiometabolic and brain health during lifespan
Acronym
SYS-LIFE
Description of the granted funding
Systemic approaches to improve cardiometabolic and brain health during lifespan (SYS-LIFE) is an exciting new postdoctoral fellowship programme that seeks to deliver urgently-needed breakthroughs in the field of cardiometabolic and brain diseases (e.g. heart attacks, strokes, depression and diabetes), promote scientific renewal in this field and develop its future leaders of tomorrow. It is based at the University of Turku (UTU) in Finland and supported by partners in different sectors. UTU’s Collegia have a record for excellence in research and for developing their researchers for leadership roles. SYS-LIFE applies their bottom-up, 'Institute for Advanced Study' model to build on UTU’s outstanding expertise and unique facilities for cardiometabolic and brain health research. It will recruit 11 experienced postdoctoral researchers (ERs) in 2023 and 2024 (22 in total), each for 36 months, through an open, international, competitive, merit-based selection process dependent on external peer-review, in line with the European Charter and Code. Projects that are interdisciplinary, intersectoral, longitudinal or systemic are encouraged. At UTU, such approaches have resulted in major advances in cardiometabolic and brain health. SYS-LIFE offers • Scientific excellence: Fellows will be free to design and pursue novel, high-quality research projects that seek to improve health outcomes in this area, connecting and strengthening research and resources at UTU and beyond; • Career development: SYS-LIFE offers mentoring and a new range of options for non-tenured researchers to develop as future leaders, enabling them to move freely between sectors to acquire unique skills and experiences; • Innovation: SYS-LIFE (i) enables knowledge and technology to circulate freely at regional, national and international levels, (ii) connects intellectual excellence with the practical know-how and infrastructure needed to realise new concepts; (iii) offers dedicated Proof-of-Concept funds.
Show moreStarting year
2023
End year
2028
Granted funding
Coordinator
Participant
TURKU SCIENCE PARK OY AB
Participant
SIEMENS HEALTHCARE GMBH (DE)
Participant
UNIVERSITEIT GENT (BE)
Participant
Amount granted
3 152 160 €
Funder
European Union
Funding instrument
HORIZON TMA MSCA Cofund Postdoctoral programme
Framework programme
Horizon Europe (HORIZON)
Call
Programme part
Marie Skłodowska-Curie Actions (MSCA) (11677Topic
MSCA COFUND 2022 (HORIZON-MSCA-2022-COFUND-01-01Call ID
HORIZON-MSCA-2022-COFUND-01 Other information
Funding decision number
101126611
Identified topics
brain, neuroscience